PC-PLD1 Antibodies

Santa Cruz Biotechnology delivers a wide array of PC-PLD1 monoclonal antibodies for research focused on phosphatidylcholine-specific phospholipase D1 (PC-PLD1). The monoclonal antibodies are suitable for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). PC-PLD1 plays a crucial role in cellular signaling and membrane dynamics by hydrolyzing phosphatidylcholine to produce phosphatidic acid, a key lipid mediator involved in various biological processes. Its importance extends to cell proliferation, migration, and the regulation of intracellular signaling pathways, making PC-PLD1 a significant target for research in cancer and other diseases. Understanding the function of PC-PLD1 can provide insights into its potential as a therapeutic target. Researchers worldwide rely on PC-PLD1 monoclonal antibodies for investigating cellular pathways and disease mechanisms. PC-PLD1 monoclonal antibodies from Santa Cruz Biotechnology enable scientists to advance their understanding of cellular processes and contribute to the development of new therapeutic strategies.